Skip to main content
. 2012 Jun 24;11:215. doi: 10.1186/1475-2875-11-215

Table 2.

Characteristics of the major clinical phenotypes

Parameter N CM N SMA N UM N RD P-value
Hyperpyrexia, n (%)
47
9 (19.1)
191
24 (12.6)
154
29 (18.8)
32
9 (28.1)
0.110
Hyperparasitaemia, n (%)
48
6 (12.5)
231
5 (2.2)
228
14 (6.1)
26
3 (11.5)
0.008
Hypoglycaemia, n (%)
49
-
187
24 (12.8)
177
18 (10.2)
26
4 (15.4)
0.617
Fatality, n (%)
47
11 (23.4)
187
11 (5.4)
154
3 (1.9)
33
5 (15.2)
<0.001
Mean age ± SD (months)
49
37.85 ± 30.15
205
29.96 ± 27.33
201
51.41 ± 38.81
33
40.28 ± 34.33
<0.001
Mean haemoglobin ± SD (g/dl)
49
6.29 ± 2.34
225
3.65 ± 0.83
222
9.60 ± 1.31
31
7.71 ± 2.27
<0.001
*GMPD, parasites/μL
48
8,578
231
7,754
228
6,791
26
17,512
0.346
Mean spleen size ± SD (cm)
41
0.95 ± 1.66
124
1.51 ± 2.37
104
1.08 ± 1.94
15
3.13 ± 3.04§
0.004
Mean plasma glucose ± SD (mmol/l) 49 6.41 ± 3.57 187 5.91 ± 4.41 177 6.23 ± 6.33 26 4.63 ± 4.25 0.474

Age significantly higher than the corresponding values for SMA (P < 0.001) and CM (P = 0.050).

§Spleen size significantly higher than the corresponding values for CM (P = 0.005), SMA (P = 0.033) and UM (P = 0.004).

The haemoglobin values are significantly different between all four clinical groups; each participant has been categorised into one group only which clinicians felt was the primary phenotype. Samples numbers in some of the clinical groups are lower because some parameter estimates were not taken.